23 November 2023
23 November 2023
A US senate committee scheduled a hearing on prescription drug pricing with major pharmaceutical companies.
Pfizer and BioNTech countersued Moderna following an initial August 2022 suit alleging that its patents were overly broad.
The warning letter issued to Cipla will further delay the launch timelines of the company’s Advair generic in the US.
The NDA has been accepted based on positive data from the Phase II TRUST-I multicentre study.
Freeline is focused on the development of innovative gene therapies for chronic debilitating diseases.
The agreement will increase the supply of and access to the Ebola vaccine across the globe.
Merz’s drug Xeomin is already approved by the FDA and EMA to treat chronic sialorrhea or excessive drooling.
The funding will advance the discovery pipeline and clinically predictive artificial intelligence (AI) stack to detect new therapeutic targets.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Only a handful of approved therapeutic drugs are currently available for the treatment of ARF, all belonging to the solute carrier family 12 member 1 inhibitor. The clinical trial space in ARF consists of almost an equal mix of commercial as well as academic sponsors, with Iran and the US emerging as the key countries for conducting Phase III trials. While the current marketed drug space for ARF has only a handful of treatment options, currently available mid-to-late-stage pipeline drugs are likely to pave the way for a new treatment approach in the future.
Give your business an edge with our leading industry insights.
